| Literature DB >> 15242255 |
Abstract
Kosan and Roche are developing the microtubule inhibitor epothilone D (KOS-862 and NSC-703147), an analog of epothilone B for the potential treatment of cancer. Phase II trials in colorectal, metastatic breast and non-small-cell lung cancers were initiated in December 2003.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15242255
Source DB: PubMed Journal: Curr Opin Investig Drugs ISSN: 1472-4472